Please assess the completion status of the following clinical trial:

Trial Title: Intestinal Permeability in Patients With Liver Cirrhosis Using Confocal Endoscopy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* liver cirrhosis~* need of upper endoscopy~* signed consent~* abdominal symptoms with indication for endoscopy~Exclusion Criteria:~* pregnancy~* Lactation~* Hypersensitivity to fluorescein~* Limited coagulation situation (Quick \<50%, PTT\> 50 sec, thrombocyte count \<50000 / μl or disturbed thrombocyte function) despite the substitution of coagulation factors / plasma products~* Limited or non-existent consent~* Restricted or inadequate ability to perform endoscopy and / or confocal imaging: restlessness of the patient, food residues, anatomical variants that make confocal imaging difficult (e.g., strictures)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Liver cirrhosis (Type: None): Patients with liver cirrhosis are included in this arm. Liver cirrhosis is diagnosed by ultrasound, CT - scan oder by clinical signs.
- Control group (Type: None): Patients with abdominal symptoms with the indication for endoscopy without liver cirrhosis and portal Hypertension.

Based on this trial design, predict the completion outcome and termination type (if applicable).